News

Alpha-gal syndrome is an increasingly common cause of gastrointestinal issues that remains underrecognized by the medical community, according to an American Gastroenterological Association clinical practice update. Although the allergic response is best known for a combination of anaphylaxis, skin changes, and gastrointestinal symptoms that occurs within hours of consuming mammalian-derived food products, health care providers should
0 Comments
[embedded content] A fire may not be the first thing that comes to mind when people consider what could go wrong in the operating room. In this video, Max Feinstein, MD, explains the training anesthesiologists receive in managing this unlikely scenario. Following is a transcript (note errors are possible): Feinstein: What would you do if
0 Comments
NEW ORLEANS, Louisiana — As the study of cutaneous dysbiosis and its role in the pathogenesis of dermatoses continues to evolve, how the mounting evidence on this topic translates into clinical practice remains largely unknown. “There’s still a lot for us to learn,” Adam Friedman, MD, professor and chair of dermatology at George Washington University,
0 Comments
The US Food and Drug Administration (FDA) has decided to withdraw approval of Makena and generic versions of the drug, the agency announced April 6. The medication was approved in 2011 to reduce the risk for preterm birth in women with a previous spontaneous preterm birth. The treatment had been approved under an accelerated pathway that
0 Comments
It’s less nature and more about noshing when it comes to the adverse impact of obesity on the heart, a twin study from Sweden suggested. In an analysis of nearly all twins in the country, obesity predicted cardiovascular disease (CVD) risk across the board in every genetic risk group, reported Ida Karlsson, PhD, of the
0 Comments
US regulators may soon clear blood-based biomarker tests for colorectal cancer (CRC), expanding potential options for patients seeking more convenient forms of screening. Most recently, Guardant Health, Inc, announced the completion of its US premarket approval application for its Shield blood test to screen for CRC. Approval by the US Food and Drug Administration (FDA)
0 Comments
When the Biden administration killed the X waiver late last year, all clinicians registered with the Drug Enforcement Administration (DEA) learned they would need 8 hours of training on substance use disorder (SUD) management in order to renew their licenses. The DEA has now issued a deadline for that requirement, and it’s less than 3
0 Comments
The youngest patient with cannabis-induced psychosis (CIP) whom Karen Randall, DO, has treated was a 7-year-old boy. She remembers the screaming, the yelling, the uncontrollable rage. Randall is an emergency medicine physician at Southern Colorado Emergency Medicine Associates, a group practice in Pueblo, Colorado. She treats youth for cannabis-related medical problems in the emergency department
0 Comments
(Reuters) – A Delaware judge on Monday dismissed Merck & Co’s lawsuit seeking to hold Bayer AG responsible for more talc-related liabilities stemming from its $14.2 billion purchase of Merck’s consumer care business in 2014. Vice Chancellor Nathan Cook of the Delaware Chancery Court said the purchase agreement “clearly and unambiguously” left Merck liable for
0 Comments
The FDA gave accelerated approval to enfortumab vedotin (Padcev) and pembrolizumab (Keytruda) as first-line treatment for certain patients with locally advanced or metastatic urothelial cancer, the agency announced on Monday. Specifically, the combination is indicated for those who are ineligible for cisplatin-containing chemotherapy, and the approval marks the first anti-PD-1/antibody-drug conjugate combination for this patient
0 Comments
Over-the-scope clips (OTSC) may prevent further bleeding more so than standard endoscopic treatment when used as primary treatment in patients with high-risk nonvariceal upper gastrointestinal lesions, shows a randomized controlled trial (RCT). However, noted the investigators, writing in Annals of Internal Medicine, and physicians who wrote an accompanying editorial, reservations remain about first-line use of OTSCs, but mostly
0 Comments
NEW ORLEANS — More than one third of pediatric residency programs do not have a pediatric rheumatologist on faculty, a situation that has changed little since 2004, according to a poster presented at the Pediatric Rheumatology Symposium 2023 conference. “This shortage has significant downstream effects,” according to author Miriah Gillispie-Taylor, MD, an assistant professor of
0 Comments
A statement released by the American Heart Association (AHA) and the American College of Cardiology (ACC) advocates use of supervised exercise training in patients with heart failure with preserved ejection fraction (HFpEF), as well as coverage for these services by third party payers. The authors hope to boost the stature of supervised exercise training (SET)
0 Comments
Smartwatches are designed to be more than just timepieces. Aside from tracking schedules, location and activities, they boast health-monitoring capabilities, especially activities affecting heart health. Many Americans spend hundreds to thousands of dollars on the latest wearable devices thinking the more sophisticated and advanced they are, the better their chances of saving their lives. But
0 Comments
Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. An antiviral therapy in early development has the potential to prevent COVID-19 infections when given as a nasal spray as little as 4 hours before exposure. It also appears to work as a treatment if used within 4 hours after infection
0 Comments
The 24-hour news cycle is just as important to medicine as it is to politics, finance, or sports. At MedPage Today, new information is posted daily, but keeping up can be a challenge. As an aid for our readers, and for a little amusement, here is a 10-question quiz based on the news of the
0 Comments